What is the recommended treatment and counseling approach for syphilis in patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Treatment and Management for Pharmacists: A Comprehensive Guide

Penicillin G remains the gold standard treatment for all stages of syphilis, with specific regimens tailored to disease stage, and doxycycline as the preferred alternative for penicillin-allergic patients. 1

Disease Overview and Staging

Syphilis is a sexually transmitted infection caused by Treponema pallidum that progresses through distinct stages if left untreated:

  • Primary syphilis: Characterized by a painless ulcer (chancre) at infection site
  • Secondary syphilis: Manifests with widespread rash, mucocutaneous lesions, and lymphadenopathy
  • Latent syphilis: Asymptomatic period with positive serology
    • Early latent: Acquired within preceding year
    • Late latent: Acquired >1 year ago or unknown duration
  • Tertiary syphilis: Includes gummatous disease, cardiovascular syphilis
  • Neurosyphilis: CNS involvement possible during any stage

Treatment Recommendations by Stage

Primary, Secondary, and Early Latent Syphilis

First-line treatment:

  • Benzathine penicillin G 2.4 million units IM in a single dose 2, 1

Alternative regimens (for penicillin-allergic, non-pregnant patients):

  • Doxycycline 100 mg orally twice daily for 14 days 2, 3
  • Tetracycline 500 mg orally four times daily for 14 days 2

Late Latent Syphilis or Latent Syphilis of Unknown Duration

First-line treatment:

  • Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at 1-week intervals 2, 1

Alternative regimens (for penicillin-allergic, non-pregnant patients):

  • Doxycycline 100 mg orally twice daily for 28 days 2
  • Tetracycline 500 mg orally four times daily for 28 days 2

Tertiary Syphilis

Recommended treatment:

  • Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at 1-week intervals 2, 1
  • CSF examination should be performed before initiating therapy 2

Neurosyphilis

First-line treatment:

  • Aqueous crystalline penicillin G 18–24 million units per day, administered as 3–4 million units IV every 4 hours or continuous infusion, for 10–14 days 2, 1

Alternative regimen:

  • Procaine penicillin 2.4 million units IM once daily PLUS
  • Probenecid 500 mg orally four times a day, both for 10–14 days 2

Special Populations

HIV-Infected Patients

  • Management is similar to HIV-negative patients, but closer follow-up is recommended 2
  • For early syphilis: Benzathine penicillin G 2.4 million units IM in a single dose 2
  • For late latent syphilis: Three weekly IM injections of 2.4 million units benzathine penicillin G 2
  • CSF examination is recommended if neurological symptoms are present 2

Pregnant Women

  • Penicillin is the only proven effective treatment during pregnancy 2
  • For penicillin-allergic pregnant women, desensitization is required 2
  • Some experts recommend an additional dose of benzathine penicillin 2.4 million units IM one week after the initial dose for pregnant women in the third trimester 1

Patient Counseling Points for Pharmacists

  1. Jarisch-Herxheimer reaction: Advise patients about this potential reaction within 24 hours of treatment, characterized by fever, headache, and myalgia 2

  2. Sexual partners: Counsel patients that:

    • Partners exposed within 90 days of diagnosis should be treated presumptively 2
    • Partners exposed >90 days before diagnosis should be treated if serologic test results are not immediately available 2
  3. Follow-up testing:

    • Quantitative nontreponemal tests should be repeated at 3,6,9,12, and 24 months after treatment 1
    • Treatment success is indicated by a fourfold decrease in titers within 6 months (primary/secondary) or 12-24 months (latent) 1
  4. HIV testing: All patients with syphilis should be tested for HIV due to high co-infection rates 2, 1

  5. Medication adherence:

    • For doxycycline: Take with food if GI irritation occurs; absorption not markedly influenced by food 3
    • For penicillin injections: Complete the full course of treatment, especially for late syphilis 4
  6. Prevention: Discuss safer sex practices, including consistent and correct condom use 1

Treatment Failure Considerations

Treatment failure or reinfection should be suspected if:

  • Clinical signs or symptoms persist or recur
  • Sustained fourfold increase in nontreponemal test titer occurs
  • Initial high titer (≥1:32) fails to decline fourfold within 12-24 months 2, 1

Re-treatment consists of three weekly injections of benzathine penicillin G 2.4 million units IM, unless neurosyphilis is suspected 1

Common Pitfalls to Avoid

  1. Inadequate follow-up: Ensure patients understand the importance of completing all follow-up serologic testing

  2. Improper treatment of pregnant women: Never use alternatives to penicillin; desensitization is required for penicillin-allergic pregnant women 2

  3. Missing neurosyphilis: Consider CSF examination in patients with neurologic, ophthalmic, or auditory symptoms 2

  4. Incomplete partner notification: Emphasize the importance of partner treatment to prevent reinfection 2

  5. Inadequate treatment of late syphilis: Do not confuse treatment regimens for early versus late syphilis; late syphilis requires 3 weekly doses of benzathine penicillin G 2, 1

  6. Overlooking drug interactions: Bacteriostatic antibiotics may antagonize the bactericidal effect of penicillin 4

References

Guideline

Syphilis Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.